The Prevalence and Clinical Impact of Leukopenia Among Arab Population with Iron Deficiency Anemia an Experience from Qatar

Abstract

Introduction Severe IDA can cause many complications and impair the quality of life. Iron is an essential micronutrient required for catalysis, DNA synthesis, redox reactions and oxygen transport1. It is important for an early step in embryonic haematopoiesis, which is common for all developing blood cells. The link between IDA and leukopenia is not well recognized in the literature. Objectives To assess the prevalence and clinical significance of leukopenia in patients with IDA and effect of iron replacement and correction of anemia on the WBCs count. Materials and Methods We retrospectively reviewed the electronic medical records of all patients attended haematology clinic with the diagnosis of iron deficiency anemia (IDA) over 2 years in Hamad Medical Corporation, Qatar. All other causes of anemia and patients with systemic or chronic diseases were excluded. Age, nationality, BMI, Complete blood count and iron parameters were collected before and after treatment with IV iron therapy. Associated infections at the time of presentation (IDA and leukopenia) were noted including the course of the infection and response to treatment. Leukopenia was defined as WBCs count below 4000/microlitre. Statistical analysis was done using paired t test to compare variables after versus before iron therapy. Results Out of 1567 case of iron deficiency anemia, 80 case had leukopenia (5.105%) Their mean Leukocytes count was 3.35 +/- 0.48 ×103 before iron replacement. 7 patients had infections; 4 had upper respiratory tract infection, 1 urinary tract infection, 1 gastroenteritis, 1 lymphadenitis. Six of them received antibiotics and they had no complications. After iron therapy and correction of anemia the leukocyte count increased significantly to 4.38 +/- 1.82×103 (P < 0.05). There was no significant correlation between WBC count and iron parameters (Hb, TIBC, serum iron concentration). Discussion High level of erythropoietin in IDA is thought to cause down regulation of neutrophils in animal models. In our study leukopenia occurred in 5.1% of the big cohort with IDA. A previous study on 516 patients with IDA recorded leukopenia in 17.6% of them. Their cases with leukopenia occurred more in patients with severe anemia. The increase of WBC count with correction of anemia suggested a physiologic link between erythropoiesis and leukopoiesis. However, our study did not show correlation between WBC count and Hb or any of the iron parameters. In concert with our finding, a study in healthy children (n = 556) did not find associations between the measured iron markers and WBC In addition, the association between IDA and leukopenia did not significantly increase the risk of infections in our patients. The link between leukopenia and IDA needs to be addressed in more studies. Conclusions: The prevalence of leukopenia in this big cohort with IDA was 5.1%. This leukopenia was not associated with severe or complicated infections. There were no associations between the measured iron markers and white blood cell counts in healthy adults Figure Disclosures No relevant conflicts of interest to declare.

Iron Therapy-Induced Leukopenia in Arab Female Population, an experience in Qatar

“…(6) Lymphopenia has a broad variety of causes, most importantly are viral infections, hematological disorders and corticosteroids therapy, (7, 8) Iron de ciency has been proposed to be infrequently associated with neutropenia and lymphopenia when other causes are ruled out. (9)(10)(11) Although parenteral iron replacement has a relatively high safety pro le, previous case reports suggested a link between iron therapy and impaired production of cell lineages like thrombocytes and leukocytes. The burden of leukopenia/neutropenia/lymphopenia as a consequent of iron therapy has not been well addressed in the literature.…”

Trends in iron deficiency anemia research 2010 – 2023: a bibliometric analysis

“…When the hepcidin concentration increases, iron is retained in enterocytes or macrophages and is not available for the production of erythrocytes. (15) When the hepcidin concentration is reduced, either because of ID or increased erythropoiesis, the iron absorbed by the enterocytes or stored in macrophages is mobilized into the circulation. (16) The interest over time in the topic of iron deficiency anemia in the whole world has increased, because iron deficiency anemia (IDA) is a widespread public health problem, particularly in low-and middle-income countries.…”